The material accounting policies are described in the notes to these Consolidated Financial Statements. The accounting policies identified in this note are applied across the preparation of the Financial Statements and were consistently applied in comparative periods, except where otherwise stated.
2.1. Basis for presentation
All amounts are shown in million euros (€ million) unless otherwise stated. Due to rounding’s, the arithmetic result of the numbers shown in the plots may not exactly match the totals.
The amounts presented for quarters, and the corresponding changes are not audited.
The Consolidated Financial Statements of JMH were prepared in accordance with International Financial Reporting Standards (IFRS) as endorsed by the European Union (EU), as at 31 December 2023.
The JMH Consolidated Financial Statements were prepared in accordance with the going concern principle and the historical cost principle, except for investment property, derivative financial instruments, biological assets and financial assets at fair value through profit or loss, which were measured at fair value (market value).
The preparation of Financial Statements in accordance with generally accepted accounting principles requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenue and expenses during the reporting period. Although these estimates are based on Management’s best knowledge of current events and actions, actual results ultimately may differ from those estimates. It is, however, firmly believed by The Management that the estimates and assumptions adopted do not involve significant risks that may, over the course of the coming financial year, cause material adjustments in the value of the assets and liabilities (note 2.6).
Change in accounting policies and basis for presentation:
2.1.1. New and amended standards adopted by the Group
Between November 2021 and November 2023, the EU issued the following Regulations, which were adopted by the Group with effect from 1 January 2023:
EU Regulation |
|
International Accounting Standards Board (IASB) Standard or International Financial Reporting Interpretations Committee (IFRIC) Interpretation endorsed by EU |
|
Issued in |
|
Mandatory for financial years beginning on or after |
---|---|---|---|---|---|---|
Regulation no. 2036/2021 |
|
IFRS 17 Insurance Contracts (new) |
|
May 2017 and June 2020 |
|
1 January 2023 |
Regulation no. 357/2022 |
|
IAS 1 Presentation of Financial Statements: Disclosure of Accounting policies (amendments) |
|
February 2021 |
|
1 January 2023 |
Regulation no. 1392/2022 |
|
IAS 12 Income Taxes: Deferred Tax related to Assets and Liabilities arising from a single transaction (amendments) |
|
May 2021 |
|
1 January 2023 |
Regulation no. 1491/2022 |
|
IFRS 17 Insurance Contracts: Initial Application of IFRS 17 Insurance Contracts and IFRS 9 Financial Instruments – Comparative Information (amendments) |
|
December 2021 |
|
1 January 2023 |
Regulation no. 2468/2023 |
|
IAS 12 Income Taxes: International Tax Reform – Pillar Two Model Rules (amendments) |
|
May 2023 |
|
1 January 2023 |
The Group adopted the above standard and amendments, with no significant impact on its Consolidated Financial Statements.
Regarding the International Tax Reform – Pillar Two Model Rules, the Group confirms the application of the exception to the recognition and disclosure of information about deferred tax assets and liabilities calculated according with the Pilar Two Model, with no amount recognized in taxes in the income statement on 31 December 2023.
The Group is analysing the Community legislation already published and the possible impacts that may arise from it, awaiting the transposition of these rules into the domestic legislation of the countries in which it operates. However, it is not anticipated that these changes may have a significant impact on the Group’s Consolidated Financial Statements.
2.1.2. New standards, amendments and interpretations endorsed by EU but not effective for the financial year beginning 1 January 2023 and not early adopted
The EU endorsed between November and December 2023 several amendments issued by the IASB, to be applied in subsequent periods:
EU Regulation |
|
IASB Standard or IFRIC Interpretation endorsed by EU |
|
Issued in |
|
Mandatory for financial years beginning on or after |
---|---|---|---|---|---|---|
Regulation no. 2579/2023 |
|
IFRS 16 Leases: Lease Liability in a sale and leaseback (amendments) |
|
September 2022 |
|
1 January 2024 |
Regulation no. 2822/2023 |
|
IAS 1 Presentation of Financial Statements: i) Classification of Liabilities as Current or Non-current (amendments); ii) Non-current Liabilities with Covenants (amendments) |
|
January and July 2020, and October 2022 |
|
1 January 2024 |
The above amendments are effective for annual periods beginning on or after 1 January 2024 and have not been applied in preparing these Consolidated Financial Statements. None of these changes are expected to have a significant impact on the Group’s Consolidated Financial Statements.
2.1.3. New standards, amendments and interpretations issued by IASB and IFRIC, but not yet endorsed by EU
IASB issued between May and August 2023 the following amendments that are still pending endorsement by the EU:
IASB Standard or IFRIC Interpretation |
|
Issued in |
|
Expected application for financial years beginning on or after |
---|---|---|---|---|
IAS 7 Statement of Cash Flows and IFRS 7 Financial Instruments: Disclosures: Supplier Finance Arrangements (amendments) |
|
May 2023 |
|
1 January 2024 |
IAS 21 The Effects of Changes in Foreign Exchange Rates: Lack of Exchangeability (amendments) |
|
August 2023 |
|
1 January 2025 |
The Management is currently evaluating the impact of adopting these amendments to standards already in place, and so far, does not expect a significant impact on the Group’s Consolidated Financial Statements.
2.1.4. Change of accounting policies
Except as disclosed above, the Group has not changed its accounting policies during 2023, nor were identified errors regarding previous years, which compel the restatement of the Consolidated Financial Statements.
2.2. Basis for consolidation
Reference dates
The Consolidated Financial Statements include, as at 31 December 2023, assets, liabilities and profit or loss of Group Companies, i.e., the ensemble consisting of JMH and its subsidiaries, joint ventures and associates, which are presented in notes 26 and 28, respectively.
Business combinations
For business combinations involving entities under common control, assets and liabilities are valued at book value and there are no impacts recognised in profit and loss.
Investments in subsidiaries
Subsidiaries are all entities over which JMH has control. The Group controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Group. They are deconsolidated from the date control ceases.
The Group applies the acquisition method to account for business combinations. The consideration transferred for the acquisition of a subsidiary is the fair value of the assets transferred, the liabilities incurred to the former owners and the equity instruments issued by the Group. The consideration transferred includes the fair value of any asset or liability resulting from a contingent consideration arrangement. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair values at the acquisition date. Acquisition-related costs are expensed as incurred.
In cases where the share capital of subsidiaries is not held at 100%, a non-controlling interest is recognised relative to the portion of results and net value of assets attributable to third parties.
When the Group loses control over a subsidiary, it derecognises the assets and liabilities of the subsidiary, and any related non-controlling interests and other components of equity. Any resulting gain or loss is recognised in profit or loss. Any interest retained in the entity is measured at fair value when control is lost.
The accounting policies used by the subsidiaries to comply with legal and statutory requirements, whenever necessary have been changed to ensure consistency with the policies adopted by the Group.
Investments in associates
Associates are all entities over which the Group has significant influence but not control, generally accompanying a shareholding between 20% and 50% of the voting rights.
Investments in associates are accounted for using the equity method of accounting. Under the equity method, the investment is initially recognised at cost, and the carrying amount is increased or decreased to recognise the Group’s share of the profit or loss of the associate after the date of acquisition. The Group’s share of post-acquisition profit or loss is recognised in the income statement, and its share of post-acquisition movements in other comprehensive income is recognised in other comprehensive income with a corresponding adjustment to the carrying amount of the investment. The Group’s investment in associates includes Goodwill identified on acquisition.
When the Group’s share of losses in an associate equal or exceeds its interest in the associate, the Group does not recognise further losses, unless it has incurred legal or constructive obligations or made payments on behalf of the associate.
Accounting policies of associates have been changed where necessary to ensure consistency with the policies adopted by the Group.
Investments in joint arrangements
Joint arrangements are classified as either joint operations or joint ventures depending on the contractual rights and obligations of each investor. The Group has assessed the nature of its joint arrangements (see note 2.6) and, for those determined as joint ventures, they are accounted for using the equity method.
Under the equity method of accounting, interests in joint ventures are initially recognised at cost and adjusted thereafter to recognise the Group’s share of the post-acquisition profits or losses and movements in other comprehensive income. When the Group’s share of losses in a joint venture equal or exceeds its interests in the joint ventures (which includes any long-term interests that, in substance, form part of the Group’s net investment in the joint ventures), the Group does not recognise further losses, unless it has incurred legal or constructive obligations or made payments on behalf of the joint ventures.
Accounting policies of the joint ventures have been changed where necessary to ensure consistency with the policies adopted by the Group.
Goodwill
Goodwill represents the surplus of acquisition cost over the fair value of identifiable assets and liabilities attributable to the Group at the date of acquisition or first consolidation. If the cost of acquisition is lower than the fair value of the net assets of the acquired subsidiary, the difference is recognised directly in the income statement.
Goodwill impairment reviews are undertaken by the Group, annually or more frequently, if events or changes in circumstances indicate a potential impairment. The carrying value of Goodwill is compared to the recoverable amount, which is the higher of value in use and the fair value less costs of disposal. Whenever the carrying value of Goodwill exceeds its recoverable amount, an impairment is recognised immediately as an expense and is not subsequently reversed (note 2.5.1).
The gain or loss on the disposal of an entity includes the carrying amount of Goodwill related to the entity sold, unless the business to which that Goodwill is related is maintained and generates benefits to the Group.
Non-controlling interests
Non-controlling interests are the proportion of the fair value of assets, liabilities and contingent liabilities of acquired subsidiaries that are not directly or indirectly attributable to JMH.
Transactions with non-controlling interests that do not result in loss of control are accounted for as equity transactions – that is, as transactions with the owners in their capacity as owners. The difference between fair value of any consideration paid and the relevant share acquired of the carrying value of net assets of the subsidiary is recorded in equity. Gains or losses on disposals to non-controlling interests are also recorded in equity.
Loss of control or significant influence
When the Group ceases to have control or significant influence, any retained interest in the entity is re-measured to its fair value, with the change in carrying amount recognised in profit or loss. The fair value is the initial carrying amount for the measurement of the retained interest as a financial asset.
Foreign currency translation
The Financial Statements of foreign entities are translated into euros based on the closing exchange rate for assets and liabilities and historical exchange rates for equity. Income and expenses are translated at the average monthly exchange rate, which is approximately the exchange rate on the date of the respective transactions.
Exchange differences arising in the translation are recognised directly in equity net of the effect generated by the respective hedging instrument (see accounting policy described in note 13).
Whenever a foreign entity is sold, accumulated exchange differences are recognised in the income statement as part of the gain or loss on sale.
Goodwill and fair value adjustments arising from the acquisition of a foreign entity are treated as assets and liabilities of the foreign entity and translated at the closing rate. Exchange differences arising are recognised in other comprehensive income.
Balances and transactions between Group Companies
Inter-company transactions, balances and unrealised gains between subsidiaries and between these and the Parent Company are eliminated in the consolidation process. Unrealised losses are also eliminated unless the cost cannot be recovered.
Unrealised gains arising from transactions with associates or joint ventures are eliminated to the extent of the Group’s interest in the associates or joint ventures. Unrealised losses are also eliminated except when providing proof of impairment of the asset transferred.
2.3. Transactions in foreign currencies
Transactions in foreign currencies are translated into the functional currency (euro) at the exchange rate prevailing on the transaction date.
At the balance sheet date, monetary assets and liabilities expressed in foreign currencies are translated at the exchange rate prevailing on that date and exchange differences arising from this conversion are recognised in the income statement. When qualifying as cash flow hedges or hedges on investments in foreign subsidiaries or when classified as other financial investments, which are equity instruments, the exchange differences are deferred in equity.
The main exchange rates applied on the balance sheet date are those listed below:
Euro foreign exchange reference rates |
|
Polish Zloty |
|
Colombian Peso |
---|---|---|---|---|
Rate at 31 December 2023 |
|
4.3395 |
|
4,223.3700 |
Average rate for the year |
|
4.5336 |
|
4,639.6600 |
Rate at 31 December 2022 |
|
4.6808 |
|
5,075.2300 |
Average rate for the year |
|
4.6883 |
|
4,479.6000 |
In addition to these currencies, the Group carries out transactions based on other currencies and holds subsidiaries with other functional currencies, which, however, represent reduced materiality.
2.4. Financial instruments
A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.
Financial instruments are offset and the net amount is reported in the Consolidated Balance Sheet if there is a currently enforceable legal right to offset the recognised amounts and there is an intention to settle on a net basis, to realise the assets and settle the liabilities simultaneously.
2.4.1. Financial assets
Initial recognition and measurement
Financial assets are classified, at initial recognition, and subsequently measured at amortised cost, fair value through other comprehensive income (OCI), fair value through profit or loss (FVTPL), or as derivatives designated as hedging instruments in an effective hedge, as appropriate.
The classification of financial assets at initial recognition depends on the financial asset’s contractual cash flow characteristics and the Group’s model adopted for managing them. With the exception of trade receivables, the Group initially measures a financial asset at its fair value plus transaction costs, in the case of a financial asset not measured at fair value through profit or loss. Transaction costs of financial assets carried at FVTPL are expensed in profit or loss. Trade receivables are measured at the transaction price determined under IFRS 15.
In order for a financial asset to be classified and measured at amortised cost or fair value through OCI, it needs to give rise to cash flows that are ‘solely payments of principal and interest (SPPI)’ on the principal amount outstanding. This assessment is referred to as the SPPI test and is performed at an instrument level. The model adopted by the Group for managing financial assets refers to how it manages its financial assets in order to generate cash flows. The model adopted determines whether cash flows will result from collecting contractual cash flows, selling the financial assets, or both.
Subsequent measurement
The subsequent measurement of financial assets depends on their classification, as described below:
- Financial assets at amortised cost
The Group measures financial assets at amortised cost if held within the adopted model, with the objective to hold financial assets in order to collect contractual cash flow, and the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.
Financial assets at amortised cost are subsequently measured using the effective interest rate (EIR) method and are subject to impairment tests. Gains and losses are recognised in profit or loss when the asset is derecognised, modified or impaired.
The Group’s financial assets at amortised cost includes mostly trade receivables. - Financial assets at fair value through OCI
The Group measures financial assets at fair value through OCI if held within the adopted model, with the objective of both holding to collect contractual cash flows and selling, and the contractual terms of the financial asset give rise, on specified dates, to cash flows that are solely payments of principal and interest on the principal amount outstanding.
For debt instruments at fair value through OCI, interest income, foreign exchange revaluation and impairment losses or reversals are recognised in the income statement and computed in the same manner as for financial assets measured at amortised cost. The remaining fair value changes are recognised in OCI. Upon derecognition, the cumulative fair value change recognised in OCI is recycled to profit or loss.
The Group does not have any financial assets under this category. - Financial assets designated at fair value through OCI (equity instruments)
Upon initial recognition, the Group can elect to classify irrevocably its equity investments as equity instruments designated at fair value through OCI when they meet the definition of equity and are not held for trading. The classification is determined on an instrument-by-instrument basis.
Gains and losses on these financial assets previously recognised in OCI are never recycled to profit or loss. Dividends are recognised as financial income in the income statement when the right of payment has been established. Equity instruments designated at fair value through OCI are not subject to impairment assessment.
The Group elected to classify irrevocably its non-listed equity investments under this category. Equity investments are accounted at cost when the fair value cannot be reliably determined. - Financial assets at fair value through profit or loss
This category corresponds to the financial assets that do not meet the criteria for amortised cost or fair value through OCI and include financial assets held for trading, financial assets designated upon initial recognition at fair value through profit or loss, or financial assets required to be measured at fair value.
Financial assets are classified as held for trading if they are acquired for the purpose of selling or repurchasing in the short term. Derivatives, including separated embedded derivatives, are also classified as held for trading unless they are designated as effective hedging instruments. Financial assets with cash flows that are not solely payments of principal and interest are classified and measured at fair value through profit or loss, irrespective of the adopted model. Financial assets at fair value through profit or loss are carried in the balance sheet at fair value with net changes in fair value recognised in the income statement.
This category includes the derivative instruments not considered for hedge accounting.
Derecognition
Financial assets are derecognised when: i. the Group’s contractual rights to receive their cash flows expire; ii. the Group has substantially transferred all the risks and rewards of ownership; or iii. although it retains a portion but not substantially all the risks and rewards of ownership, the Group has transferred control over the assets.
2.4.2. Financial liabilities
Initial recognition and measurement
Financial liabilities are classified, at initial recognition, as financial liabilities at fair value through profit or loss, loans and borrowings, payables, or as derivatives designated as hedging instruments in an effective hedge, as appropriate.
All financial liabilities are recognised initially at fair value and, in the case of loans and borrowings and payables, net of directly attributable transaction costs.
The Group’s financial liabilities include trade and other payables, loans and borrowings including bank overdrafts, and derivative financial instruments.
Subsequent measurement
The measurement of financial liabilities depends on their classification, as described below:
- Financial liabilities at fair value through profit or loss
Financial liabilities at fair value through profit or loss include financial liabilities held for trading and financial liabilities designated upon initial recognition at fair value through profit or loss.
Financial liabilities are classified as held for trading if they are incurred for the purpose of repurchasing in the short term. This category also includes derivative financial instruments entered into by the Group that are not designated as hedging instruments in hedge relationships as defined by IFRS 9. Gains or losses on liabilities held for trading are recognised in the income statement. - Financial liabilities at amortised cost
After initial recognition, trade and other creditors, interest-bearing loans and borrowings are subsequently measured at amortised cost using the effective interest rate method (EIR). Gains and losses are recognised in profit or loss when the liabilities are derecognised as well as through the EIR amortisation process.
Amortised cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the EIR. The EIR amortisation is included as financial costs in the income statement.
Derecognition
A financial liability is derecognised when the obligation under the liability is discharged, cancelled, or expires. When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as the derecognition of the original liability and the recognition of a new one. The difference in the respective carrying amounts is recognised in the income statement.
2.5. Impairment
2.5.1. Impairment of non-financial assets
Except for investment property, inventories (note 14) and deferred tax assets (note 7.3), all Group assets are analysed at each balance sheet date in order to assess for indicators of possible impairment losses. If such indicators exist, the asset’s recoverable amount is estimated.
Irrespective of whether there is any indication of impairment, for Goodwill, intangible assets not yet available for use and other intangible assets with indefinite useful life, the recoverable amount is determined annually at the balance sheet date.
The recoverable amount of the Group’s assets with indicators of potential impairment loss is determined annually. Whenever the carrying value of an asset, or the cash-generating unit to which the same belongs, exceeds its recoverable amount, its value is reduced to the recoverable amount and the impairment loss recognised in the income statement of the year.
Determining the recoverable amount of assets
The recoverable amount of non-financial assets corresponds to the higher amount of fair value less costs of disposal and value in use.
The value in use of an asset is calculated as the present value of estimated future cash flows. The discount rate used is a pre-tax rate that reflects current market assessments of the time value of money and the specific risks of the asset in question.
The recoverable amount of assets that do not generate independent cash flow is determined together with the cash-generating unit to which these assets belong.
Reversal of impairment losses
An impairment loss recognised related to Goodwill is not reversed.
Impairment losses for other assets are reversed whenever there are changes in the estimates used to determine the respective recoverable amount. Impairment losses are reversed to the extent of the amount, net of amortisation or depreciation, that would have been determined for the asset if no impairment loss were recognised.
2.5.2. Impairment of financial assets
Customers, debtors and other financial assets
The Group recognises an impairment for Expected Credit Losses (ECLs) for financial assets not held at fair value through profit or loss. ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash flows that the Group expects to receive, discounted base on estimation of the original effective interest rate. The estimated cash flows will include cash flows from the sale of collateral held or other credit enhancements that are integral to the contractual terms.
ECLs are recognised in two stages. For credit exposures for which there has not been a significant increase in credit risk since initial recognition, ECLs are provided for credit losses that result from default events that are possible within the next 12-months (a 12-month ECL). For those credit exposures for which there has been a significant increase in credit risk since initial recognition, a loss allowance is required for credit losses expected over the remaining life of the exposure, irrespective of the timing of the default (a lifetime ECL).
For trade receivables, the Group applies a simplified approach in calculating ECLs, not tracking changes in credit risk, but instead recognises a loss allowance based on lifetime ECLs at each reporting date. When performing the loss allowance assessment, the Group takes into consideration the historical credit loss experience, adjusted to forward looking factors specific to the debtors or the economic environment.
The Group considers a financial asset in default when contractual payments are 90 days past due. However, in certain cases, the Group may also consider a financial asset to be in default when internal or external information indicates that the Group is unlikely to receive the outstanding contractual amounts in full before taking into account any credit enhancements held by the Group.
A financial asset is written off when there is no reasonable expectation of recovering the contractual cash flows.
2.6. Critical accounting estimates and judgments on the preparation of the Financial Statements
Tangible fixed assets, Intangible assets, and Investment property
Determining the fair value of investment property, as well as the useful life of assets, is based on Management estimates. Determining impairment losses of these tangible and intangible assets also involves the use of estimates. The value in use or the fair value of these assets (including Goodwill) are normally determined using the discounted cash flow method, which incorporates market assumptions. Identifying indicators of impairment, as well as estimating future cash flows and determining the fair value of assets, requires significant judgment by Management in validating indicators of impairment, expected cash flows, applicable discount rates, estimated useful life and residual values.
The Group monitors the potential impacts arising from climate change, as well as any associated legislative changes that may affect its business and asset. So far, no impacts related to climate change have been identified that could materially affect the recovery of the Group’s assets. However, if justified, Management will review the assumptions used in the measurement of value in use, estimates of useful lives and in the sensitivity analysis carried out.
In a particularly uncertain international context, the Group maintained a conservative perspective in the annual review of the business plans of the Companies.
According to current projections of the business areas, if the cash flow assumptions were reduced by 10% compared to the estimates, or if the discount rate was higher by 100 bps, all Goodwill would still be recoverable and there would be no risk of impairment (see note 9.4).
Determining the lease term of contracts with renewal and termination options – Group as lessee
The Group determines the lease term as the non-cancellable term of the lease, together with any periods covered by an option to extend the lease if it is reasonably certain to be exercised, or any periods covered by an option to terminate the lease, if it is reasonably certain not to be exercised.
The Group has several lease contracts that include extension and termination options and applies judgement in evaluating whether it is reasonably certain whether or not to exercise the option to renew or terminate the lease. That is, it considers all relevant factors that create an economic incentive for it to exercise either the renewal or termination. After the commencement date, the Group reassesses the lease term if there is a significant event or change in circumstances that is within its control and affects its ability to exercise or not to exercise the option to renew or to terminate (e.g., leasehold improvements or significant customization to the lease asset). These options are used to maximize operational flexibility in terms of managing contracts. A significant part of extension and termination options held are exercisable only by the Group companies and not by the respective lessor.
Leases – Estimating the incremental borrowing rate (IBR)
The Group cannot readily determine the interest rate implicit in most leases, therefore, it uses its IBR to measure lease liabilities. The IBR is the rate of interest that the Group would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment. The IBR therefore reflects what the Group ‘would have to pay’, which requires estimation when no observable rates are available (such as for subsidiaries that do not enter into financing transactions) or when they need to be adjusted to reflect the terms and conditions of the lease (for example, when leases are not in the subsidiary’s functional currency). The Group estimates the IBR using observable inputs (such as market interest rates), when available, and is required to make certain entity-specific estimates. The average IBR used by the Group to discount the lease liabilities was 6.35% (5.92% as of 31 December 2022).
Fair value of financial instruments
The fair value of financial instruments not quoted on an active market is determined based on valuation methods. The use of valuation methodologies requires the use of assumptions, with some assumptions resulting from estimates. Therefore, changes in those assumptions could result in a change in the fair value reported (see note 13).
Deferred taxes
Recognising deferred taxes assumes the existence of results and future taxable income. Deferred tax assets and liabilities were determined based on tax legislation currently effective for the Group Companies, or on legislation already published for future application. Changes in the tax legislation may influence the value of deferred taxes.
If the rates used to recognise deferred taxes increase by 1 p.p., the impact in Group accounts would be the following:
|
|
Impact on Group accounts |
||
---|---|---|---|---|
|
|
Income statement |
|
Other comprehensive income |
Portugal |
|
2 |
|
0 |
Poland |
|
4 |
|
(0) |
A positive amount means a gain in Group accounts.
Impairment losses of clients and debtors
The Management maintains impairment losses for clients and debtors, in order to reflect the estimated losses resulting from clients’ inability to make payments on the required dates and for the contracted amounts. When evaluating the reasonableness of the adjustment for the impairment losses, Management bases its estimates on an analysis of the ageing of the accounts receivable from its clients, its historical experience of write-offs, the client’s credit history, changes in the client’s payment terms and forward-looking factors specific to the debtors and the economic environment. If the client or debtor’s financial conditions deteriorate, impairment losses and actual write-offs may be higher than expected.
Pensions and other long-term benefits granted to employees
Determining obligations for pension and other long-term benefits requires the use of assumptions and estimates, including actuarial projections and other factors that may impact the costs and obligations for the benefit plans.
In determining the appropriate discount rate, Management considers the interest rates of corporate bonds with an ‘AA’ rating or above, as set by an internationally acknowledged rating agency. These rates are extrapolated as needed along the yield curve to correspond with the expected term of the defined benefit obligation.
The definition of the criteria to select the corporate bonds to include in the population from which the yield curve is derived, requires judgement, the most significant being the selection of the size of the population, the bond issue size, the quality of the bonds, and identification of outliers data to exclude.
Considering the information available from Bloomberg and some necessary estimation to derive the yield curve, the Group defined the following ranges:
Portugal (PT)
- Narrow range [3.60%-4.00%]
- Extended range [3.40%-4.20%]
Based on these results and following the recommendation of the external actuaries, the Group has decided to increase its discount rate from 3.30% to 3.80%.
Poland (PL)
- Narrow range [5.10%-5.50%]
- Extended range [4.90%-5.70%]
Based on these results and following the recommendation of the external actuaries, the Group has decided to decrease its discount rate from 6.50% to 5.30%.
The table below shows the impacts on the obligations with defined benefit plans of the Group, resulting from changes in the following assumptions:
|
|
Assumption used |
|
Impact on defined benefit obligations |
||||||
---|---|---|---|---|---|---|---|---|---|---|
|
|
PT |
|
PL |
|
Change in assumption |
|
Increase in assumption |
|
Decrease in assumption |
Discount rate |
|
3.80% |
|
5.30% |
|
0.50% |
|
(2) |
|
2 |
Salary growth rate |
|
|
|
|
|
|
|
|
|
|
short term |
|
4.00% |
|
9.9%-15% |
|
0.50% |
|
2 |
|
(2) |
long term |
|
3.00% |
|
4%-5% |
|
|
|
|||
Pension growth rate |
|
4.00% |
|
‐ |
|
0.50% |
|
‐ |
|
‐ |
Life expectancy |
|
TV 88/90 |
|
GUS 2020 |
|
1 year |
|
1 |
|
(1) |
A positive amount means an increase in liabilities. A negative amount means a decrease in liabilities.
Provisions
The Group exercises considerable judgment in measuring and recognising provisions and its exposure to contingent liabilities related to legal proceedings, both in litigation or with a high probability of resulting in litigation. This judgment is necessary to determine the probability that a lawsuit may be successful, or to record a liability. Provisions are recognised when the Group expects that proceedings under way will result in cash outflows, the loss is considered probable and may be reasonably estimated. Due to the uncertainties inherent in the evaluation process, actual losses may be different from those originally estimated. These estimates are subject to changes as new information becomes available, mainly with the support of internal specialists, if available, or through the support of external consultants, such as actuaries or legal advisers. Changes to estimates of potential losses on proceedings under way, may significantly affect future results.
Investment in associates
The Management assessed the level of influence that the Group has on Novo Verde – Sociedade Gestora de Resíduos de Embalagens, S.A., with a percentage of control of 40% and a percentage of interest of 20.4%. Given the legal regime applicable to waste management companies, which prevent this type of company from distributing reserves and retained earnings to its shareholders, this investment cannot be classified in the Group’s accounts as an associate and has therefore been classified as other financial investments.
Investment in joint arrangements
The Group holds 51% of the voting rights of its joint arrangement in JMR – Gestão de Empresas de Retalho, SGPS, S.A. (JMR). Based on the contractual arrangements with the other Investor, the Group has the power to appoint and remove the majority of members of the Board of Directors. In addition, all key management personnel with the powers to conduct the relevant activities of JMR are employees of another company 100% owned by Jerónimo Martins. For these reasons, the Management concluded that the Group has the practical ability to direct the relevant activities of JMR and hence has the control over the Company. Therefore, JMR is classified as a subsidiary, as well as all entities directly controlled by JMR.
2.7. Investment properties
Investment property are land and buildings that are accounted at fair value, determined by specialised independent entities, with appropriate recognised professional qualifications and experience in valuing assets of this nature.
The fair value is based on market values, being the amount at which two independent willing parties would be interested in making a transaction of the asset.
The methodology adopted in the valuation and determination of fair value consists of applying the market’s comparative method, in which the asset under valuation is compared with other similar assets that perform the same function, negotiated recently in the same location or in comparable zones. The known transaction values are adjusted to make a proper comparison, and the variables of size, location, existing infrastructure, state of conservation and other variables that may be relevant in some way are considered.
In addition, and particularly in cases in which comparison with transactions that have occurred is difficult, an income approach is used. It is assumed that the value of the asset corresponds to the present value of all the future benefits and rights arising from its ownership.
For this purpose, an estimation of the market rent is used, considering all the endogenous and exogenous variables of the asset under valuation, and a yield that reflects the risk of the market of which that asset is a part, as well as the characteristics of the asset itself.
Changes to fair value of investment property are recognised in the income statement, in gains/(losses) in other investments, since it is related with assets owned for appreciation.
2.8. Fair value of financial instruments
To determine the fair value of a financial asset or liability, the market price is applied, if such a market exists. A market is regarded as active if quoted prices are readily and regularly available from an exchange, broker or regulatory agency, and those prices represent actual and regularly occurring market transactions on an arm’s length basis (level 1). Otherwise, which is the case of some financial assets and liabilities, valuation techniques that are generally accepted in the market are used based on market assumptions.
The Group applies valuation techniques for unlisted financial instruments, such as derivatives, fair value financial instruments held for sale and biological assets through profit and loss. The evaluation models most frequently used are discounted cash flow and options models which incorporate, for example, interest rate curves and market volatility (level 2). For derivatives valuation, the Group also uses the valuations provided by the counterparties.
When measuring fair value, Management considered the potential impact of climate change, including changes to legislation, which may affect the determination of the fair value of financial assets and liabilities recognised in the financial statements. Risks associated with climate change are included as key assumptions when they materially impact the measurement of the recoverable amount. Currently, the impact of climate change in not material in the cash flows used in the measurement of values in use.
Cash and cash equivalents, debtors and accruals
These financial instruments include mainly short-term financial assets and for that reason their accounting value at the reporting date is considered approximately their fair value.
Other financial investments
Listed financial instruments are recognised in the balance sheet at their fair value. The equity investments are stated at cost, reduced by any impairment loss, since its fair value cannot be reliably measured.
Borrowings
The fair value of borrowings is obtained from the discount cash flow of all expected payments. The expected cash flows are discounted using actual market interest rates. At the reporting date the carrying value is approximately its fair value.
Creditors and accruals
These financial instruments include mainly short-term financial liabilities, and for that reason their accounting value at the reporting date is considered approximately their fair value.
2.9. Fair value hierarchy
The following table shows the Group’s assets and liabilities that are measured at fair value at 31 December according to the following fair value hierarchy levels:
- Level 1: The fair value of financial instruments is based on quoted prices obtained in active and liquid markets at balance sheet date. This level includes other financial investments with shares listed on the stock exchange;
- Level 2: The fair value is determined using valuation models, which may involve other comparable quoted prices obtained in active markets or adjusted quotes. Thus, main inputs used on these valuation models are based on observable market data. This level includes biological assets and the over-the-counter derivatives entered into by the Group, whose valuations are provided by the respective counterparties;
- Level 3: The fair value is determined using valuation models, whose main inputs are not observable in the market, prepared by independent external experts. This level includes investment properties and derivative financial instruments, whose valuation, in the case of the latter, used discounted cash flow model, considering inputs not observable in the market, namely electricity prices.
2023 |
|
Total |
|
Level 1 |
|
Level 2 |
|
Level 3 |
---|---|---|---|---|---|---|---|---|
Assets measured at fair value |
|
|
|
|
|
|
|
|
Investment property |
|
9 |
|
‐ |
|
‐ |
|
9 |
Biological assets |
|
|
|
|
|
|
|
|
Consumable biological assets |
|
23 |
|
‐ |
|
8 |
|
15 |
Bearer biological assets |
|
3 |
|
‐ |
|
3 |
|
‐ |
Derivative financial instruments |
|
|
|
|
|
|
|
|
Derivatives held for trading |
|
6 |
|
‐ |
|
6 |
|
‐ |
Total assets |
|
42 |
|
‐ |
|
17 |
|
24 |
Liabilities measured at fair value |
|
|
|
|
|
|
|
|
Derivative financial instruments |
|
|
|
|
|
|
|
|
Derivatives held for trading |
|
6 |
|
‐ |
|
‐ |
|
6 |
Derivatives used for hedging |
|
12 |
|
‐ |
|
12 |
|
‐ |
Total liabilities |
|
18 |
|
‐ |
|
13 |
|
6 |
2022 |
|
Total |
|
Level 1 |
|
Level 2 |
|
Level 3 |
---|---|---|---|---|---|---|---|---|
Assets measured at fair value |
|
|
|
|
|
|
|
|
Investment property |
|
9 |
|
‐ |
|
‐ |
|
9 |
Other financial investments |
|
|
|
|
|
|
|
|
Equity instruments |
|
16 |
|
16 |
|
‐ |
|
‐ |
Biological assets |
|
|
|
|
|
|
|
|
Consumable biological assets |
|
16 |
|
‐ |
|
7 |
|
9 |
Bearer biological assets |
|
3 |
|
‐ |
|
3 |
|
‐ |
Derivative financial instruments |
|
|
|
|
|
|
|
|
Derivatives held for trading |
|
2 |
|
‐ |
|
2 |
|
‐ |
Total assets |
|
45 |
|
16 |
|
11 |
|
18 |
Liabilities measured at fair value |
|
|
|
|
|
|
|
|
Derivative financial instruments |
|
|
|
|
|
|
|
|
Derivatives held for trading |
|
6 |
|
‐ |
|
‐ |
|
5 |
Derivatives used for hedging |
|
9 |
|
‐ |
|
9 |
|
‐ |
Total liabilities |
|
14 |
|
‐ |
|
9 |
|
5 |
2.10. Financial instruments by category
|
|
Financial assets or liabilities at fair-value through results |
|
Derivatives defined as hedging instruments |
|
Financial assets or liabilities at fair-value through OCI |
|
Financial assets or liabilities at amortized cost |
|
Total financial assets and liabilities |
|
Non-financial assets and liabilities |
|
Total assets and liabilities |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
‐ |
|
‐ |
|
‐ |
|
1,938 |
|
1,938 |
|
‐ |
|
1,938 |
Other financial investments |
|
‐ |
|
‐ |
|
2 |
|
‐ |
|
2 |
|
‐ |
|
2 |
Debtors, accruals and deferrals |
|
‐ |
|
‐ |
|
‐ |
|
796 |
|
796 |
|
92 |
|
888 |
Derivative financial instruments |
|
6 |
|
0 |
|
‐ |
|
‐ |
|
6 |
|
‐ |
|
6 |
Other non-financial assets |
|
‐ |
|
‐ |
|
‐ |
|
‐ |
|
‐ |
|
11,463 |
|
11,463 |
Total assets |
|
6 |
|
0 |
|
2 |
|
2,735 |
|
2,742 |
|
11,554 |
|
14,297 |
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Borrowings |
|
‐ |
|
‐ |
|
‐ |
|
765 |
|
765 |
|
‐ |
|
765 |
Lease liabilities |
|
‐ |
|
‐ |
|
‐ |
|
3,382 |
|
3,382 |
|
‐ |
|
3,382 |
Derivative financial instruments |
|
6 |
|
12 |
|
‐ |
|
‐ |
|
18 |
|
‐ |
|
18 |
Creditors, accruals and deferrals |
|
‐ |
|
‐ |
|
|
|
6,204 |
|
6,204 |
|
506 |
|
6,709 |
Other non-financial liabilities |
|
‐ |
|
‐ |
|
‐ |
|
‐ |
|
‐ |
|
355 |
|
355 |
Total liabilities |
|
6 |
|
12 |
|
‐ |
|
10,351 |
|
10,370 |
|
861 |
|
11,231 |
2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
‐ |
|
‐ |
|
‐ |
|
1,781 |
|
1,781 |
|
‐ |
|
1,781 |
Other financial investments |
|
‐ |
|
‐ |
|
17 |
|
‐ |
|
17 |
|
‐ |
|
17 |
Debtors, accruals and deferrals |
|
‐ |
|
‐ |
|
‐ |
|
566 |
|
566 |
|
85 |
|
652 |
Derivative financial instruments |
|
2 |
|
0 |
|
‐ |
|
‐ |
|
2 |
|
‐ |
|
2 |
Other non-financial assets |
|
‐ |
|
‐ |
|
‐ |
|
‐ |
|
‐ |
|
9,393 |
|
9,393 |
Total assets |
|
2 |
|
0 |
|
17 |
|
2,348 |
|
2,367 |
|
9,478 |
|
11,845 |
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Borrowings |
|
‐ |
|
‐ |
|
‐ |
|
470 |
|
470 |
|
‐ |
|
470 |
Lease liabilities |
|
‐ |
|
‐ |
|
‐ |
|
2,678 |
|
2,678 |
|
‐ |
|
2,678 |
Derivative financial instruments |
|
6 |
|
9 |
|
‐ |
|
‐ |
|
14 |
|
‐ |
|
14 |
Creditors, accruals and deferrals |
|
‐ |
|
‐ |
|
‐ |
|
5,401 |
|
5,401 |
|
401 |
|
5,802 |
Other non-financial liabilities |
|
‐ |
|
‐ |
|
‐ |
|
‐ |
|
‐ |
|
295 |
|
295 |
Total liabilities |
|
6 |
|
9 |
|
‐ |
|
8,550 |
|
8,564 |
|
696 |
|
9,260 |